10 pharma and biotech VC arms to know about
This issue of our newsletter is supported by Inpart.
Venture capital is vital in the biotech industry to help startups achieve the success they desire.
Of course, there are plenty of established companies set up as VC firms, such as Third Rock Venture and Sofinnova.
But did you know that, over the years, many big pharma and biotech companies have also decided to spin out their own venture capital funds?
This is in an effort to scout and invest early in potential acquisitions.
This week, we explore 10 notable pharma and biotech VC capital arms.
To find out more, read the full article: “10 notable pharma and biotech venture capital arms”
A MESSAGE FROM OUR SPONSOR INPART
Find your next industry partner
Advance your research, generate impact, and secure funding by partnering with industry teams around the world. View requests for proposals and calls for partnering from companies including LEO Pharma and Topsoe.
🔥 More noteworthy articles from this week:
Some of the deadliest cancer mutations occur in a gene called KRAS; drugs that target this gene to stop cancer cells from growing further are known as KRAS inhibitors, which have been regarded as a step forward in cancer research and appear to hold clinical promise.
Recommended by LinkedIn
Prime editing, which is seen as a mightier version of CRISPR/Cas9 technology, has been part of rigorous research and development in recent years and, now, U.S. regulators have greenlit the first-ever clinical trial for this technology.
In the biotech industry, having a strong company culture is essential for success, as it helps attract top talent, keeps employees motivated, and fosters an environment where innovation can flourish. Here we explored how biotech companies can define their mission, purpose, and vision, and how these elements impact company culture, leading to better employee engagement and organizational success.
According to a report, in 2023, the Swiss biotech industry achieved record revenues of $8 billion (CHF 7.3 billion) and raised over $2.2 billion (CHF 2 billion) in capital investments, marking a significant 50% increase from 2022. In this article, we look into the findings of this report, providing an overview of the growth, challenges, and prospects of the Swiss biotech industry.
With more than 1,000 life science companies and rigorous research conducted by globally-renowned Karolinska Institutet and other leading institutions, Sweden has a booming biotech industry. In this article, we take a look at eight of Sweden’s top biotech companies.
Myasthenia gravis is a chronic autoimmune disorder where antibodies destroy the communication between nerves and muscle, and this results in weakness of the skeletal muscles. As June is myasthenia gravis awareness month, we had a conversation with Dana Vigier, head of Central Eastern and Northern Europe at Alexion to gain more insight on the disease.
Quality control (QC) testing is essential to ensure the efficacy and safety of therapeutic biologics. Even though state-of-the-art molecular methods are well established, laboratories still primarily rely on animal testing, using protocols developed in the 1970s.
📣 Shape Labiotech's future! Take our survey by June 2nd for a chance to win a €250/$250 Amazon gift card.
Your insights are crucial to us! Don't miss out – click now to have your voice heard.
💡Enjoying these articles? Never miss a single publication of Labiotech by becoming a part of our community! Click here to join our mailing list.